BENSALEM, Pa.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/search?q=%24XENT&src=ctag” target=”_blank”gt;$XENTlt;/agt; lt;a href=”https://twitter.com/hashtag/classaction?src=hash” target=”_blank”gt;#classactionlt;/agt;–Law Offices of Howard G. Smith announces an investigation on behalf of
Intersect ENT, Inc. (“Intersect ENT” or the “Company”) (NASDAQ: XENT)
investors concerning the Company and its officers’ possible violations
of federal securities laws.
On May 6, 2019, the Company disclosed a first quarter loss of $10.8
million, as well as a lowered guidance for the remainder of 2019. In
addition to this news, the Company also reported that its CEO of 11
years will be stepping down on June 5th.
On this news, the Company’s share price fell sharply during intraday
trading, thereby injuring investors.
If you purchased Intersect ENT securities, have information or would
like to learn more about these claims, or have any questions concerning
this announcement or your rights or interests with respect to these
matters, please contact Howard G. Smith, Esquire, of Law Offices of
Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania
19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by
email to [email protected],
or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.
Contacts
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
[email protected]
www.howardsmithlaw.com
